Biotechnology from bench to business

• Follow GEN on:
• Login | Register | Subscribe

• ADME/Tox
• Automation
• Bioprocess Scale-Up
• Bioreactors
• Biosimilars
• Cell Culture
• Cell-Based Assays
• Contract Manufacturing
• Gene Therapy
• High-Throughput Screening
• Immunoassay
• Induced Pluripotent Stem Cells
• Informatics
• Liquid Handling
• Protein Characterization
• Protein Detection
• Regenerative Medicine
• RNAi/siRNA
• Stem Cells
• Western Blot

• GEN Articles

• More »

• Corporate Profiles: Re-Editing the Genome for Mistakes of Nature
  Cellectis Says It Can Cut and Paste DNA Sequences with Its "Molecular Scissors"

• GEN News Highlights

• More »

• Cellectis Wins Second NIH iPSC Contract
  
• Cellectis Wins Up to $9.5M NIH Stem Cell Contract
  
• Medicago Taps Cellectis to Boost Therapeutic Protein Production in Tobacco Plants
  
• Ectycell and Caisse des Depots Pledge €12M for Development of Industrial iPSC Platform
  
• Cellectis Nabs TAL Effector IP from Minnesota and Iowa State Universities
  

• New Products

• More »

	Cellectis bioresearch Gene-Editing Services Custom TALEN™ services can help researchers with gene-editing projects including gene knockout, gene tagging, promoter swapping, and nucleotide substitution. Project support managers can provide users with expertise to achieve customized cells and
	Cellectis bioresearch Cell-Line Customization Service Gene customization experts can modify cell lines at any gene, at any position. Services available include gene modification, knock-out, and targeted transgene integration. Thirteen years of genome customization expertise, TALEN™ technology, and IP
	Cellectis bioresearch Methylated Gene Targeting TALEN™ CpG™ is a service designed to overcome the impact of methylated DNA on TALEN nuclease activity. Users can target any gene at any position in any cell type regardless of methylation status. The service can make gene editing accessible for the
	Cellectis bioresearch Knockout Cell Lines for Cancer Research The cells in CanCELL™ cell lines represent comprehensive knockouts of major disease-relevant oncogenes and tumor suppressor genes. CanCELL cell lines are generated using TALEN™ technology and offer opportunities to study signaling pathways and gene